The Right Prescription: Open Innovation
October 14, 2013 Editor 0
The Business Standard website reported that the rising cost of drug discovery makes it pertinent to look at alternate models to approach innovation. The ‘Open Innovation model’ has emerged as an interesting alternative. It is based upon openness and collaboration, which is in complete contrast to closely guarded and internally focused traditional R&D models typically seen in the pharmaceutical industry. An open innovation model enables organizations to exchange ideas and thoughts from outside in a structured manner, thus potentially augmenting capacity, providing massive parallel processing and improving the innovation funnel.
Click here to read the full article.
Categories: Open Innovation
Subscribe to our stories
- In pictures: the 2019 Africa RISING Tanzania monitoring visit August 30, 2019
- Active Internationalization of Software Enterprises: Scale Development and Validation August 30, 2019
- The Manager’s Guide to Leveraging Disruption August 30, 2019
- Key take-aways from a recent Africa RISING exchange visit in Ghana August 30, 2019
- Device that recycles vaporized water from power plants wins MIT $100K May 28, 2019